TG and Cognitive impairment: The primary objective was to determine whether thyroid hormone abnormalities have an explanatory value for reduced OF at different stages of early cognitive impairment, particularly in subjective cognitive decline (SCD) and non-amnestic (naMCI) and amnestic mild cognitive impairment (aMCI) patients.